Health
Lyra Health Expands Substance Use Disorder Support
Mental health company Lyra Health is now offering services for people struggling with cannabis, stimulants, opioids and nicotine. The post Lyra Health Expands...
What the 2024 Election Could Mean for Health Coverage, Affordability, and the Budget
As the 2024 presidential election draws near, there are sharp differences in former President Trump’s and Vice President Harris’ records on health coverage...
One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2022
This analysis examines the competitiveness of markets for hospital care based on the share of metropolitan areas controlled by a small number of...
The Surprising Link Between Calf Muscle Exercise and Heart Attack Prevention
It may seem surprising, but there is a connection between the heart and calf muscles. Just like how there’s talk about how root...
Why aren’t people using Paxlovid?
Paxlovid (nirmatrelvir-ritonavir) is effective at preventing hospitalization and death from COVID-19, but few people use it. A paper by SteelFisher et al. (2024)...
INVEST Pitch Perfect Spotlight: How One Startup Aims To Become the Leading Medicaid Mental Health Provider for Kids
Healthy Young Minds is an online youth mental health startup. It was recently crowned winner of MedCity News’ INVEST Pitch Perfect contest focused...
13 Pitfalls That Spell Doom for Google Ad Conversions & How to Fix Them
Managing successful Google Ads campaigns is more than just winning clicks—it’s about converting those clicks into results (e.g., new patients or B2B inquiries)....
Cluster Headaches: Battling the Unseen Beast
Step into the unpleasant reality of cluster headaches and the silent battle many undergo, with the hope of a cure.
Experts Warn of Strong Link Between Alcohol and Six Types of Cancer
A recent report underscores a significant link between excessive alcohol consumption and the risk of six types of cancer, including breast, colorectal and...
Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD
Dupixent, a Sanofi and Regeneron Pharmaceuticals drug, is now approved for chronic obstructive pulmonary disease (COPD), a progressive lung disease prevalent in smokers....
